Shire Specialty Pharmaceuticals President Mike Cola: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Shire’s head of ADHD, renal and GI products talks about upcoming launches, a sales force reconfiguration and licensing and acquisitions.
You may also be interested in...
Shire Specialty Pharmaceuticals President Mike Cola: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
Company is looking to do deals in three therapeutic areas, Cola says.
Shire Specialty Pharmaceuticals President Mike Cola: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
Company is looking to do deals in three therapeutic areas, Cola says.
Shire Confident Of Vyvanse Approval, Despite Second ‘Approvable’ Letter
Adderall XR follow-on still slated for Q2 2007 launch.